Compagnie Lombard Odier SCmA’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-110
Closed -$12.2K – 448
2024
Q3
$12.2K Hold
110
– – ﹤0.01% 401
2024
Q2
$10.8K Buy
+110
New +$11.2K ﹤0.01% 392
2017
Q2
– Sell
-732
Closed -$60K – 714
2017
Q1
$60K Buy
+732
New +$57.6K ﹤0.01% 522
2016
Q3
– Sell
-2,000
Closed -$156K – 907
2016
Q2
$156K Hold
2,000
– – ﹤0.01% 507
2016
Q1
$164K Buy
+2,000
New +$163K 0.01% 521
2015
Q2
– Sell
-2,144
Closed -$194K – 844
2015
Q1
$194K Hold
2,144
– – 0.01% 496
2014
Q4
$173K Sell
2,144
-6,508
-75% -$514K 0.01% 435
2014
Q3
$649K Buy
8,652
+10
+0.1% +$728 0.03% 267
2014
Q2
$593K Sell
8,642
-271
-3% -$18.4K 0.02% 285
2014
Q1
$623K Hold
8,913
– – 0.03% 283
2013
Q4
$595K Buy
+8,913
New +$545K 0.03% 287

Other funds holding CAH

Compagnie Lombard Odier SCmA's CAH Position: Q4 2024 in Review

Compagnie Lombard Odier SCmA sold out of Cardinal Health (CAH) in Q4 2024, closing a stake of 110 shares — an estimated $12.2K sold.

Compagnie Lombard Odier SCmA first reported a position in CAH in Q4 2013 and held it in 11 quarters. The position peaked at $649K in Q3 2014. 1,100 funds tracked by Wall St. Rank hold CAH as of Q4 2024.

  • Compagnie Lombard Odier SCmA reported no remaining Cardinal Health position as of Q4 2024 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 110 Cardinal Health shares in Q4 2024, an estimated $12.2K.
  • Compagnie Lombard Odier SCmA first reported a position in Cardinal Health in Q4 2013 and held it in 11 quarters.
  • Compagnie Lombard Odier SCmA's Cardinal Health position peaked at $649K in Q3 2014.
  • 1,100 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2024.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2024, filed 30 Jan 2025.